Loading the content... Loading depends on your connection speed!
|
Risk Factors of Olszewski et al for 30-Day Mortality in an Older Adult with Diffuse Large B-Cell Lymphoma (DLBCL) After Rituximab-Based Immunochemotherapy |
MyLikes |
MyPaths |
In order to access the algorithms, please subscribe to a plan that fits your needs.